Cystic fibrosis
Liverpool suggested that this was not the casemany families reported difficulties in obtaining and keeping the allowance.
Experiences claiming attendance allowance In June 1990 all patients attending the clinic were sent a questionnaire asking whether attendance allowance was currently received and whether the allowance had ever been stopped. They were also asked for information about any appeals that had been made and the period of time between application and receipt of the allowance.
The age of the patient was obtained from clinic records and a measure of disease severity was obtained by reference to their most recent modified Shwachman score.' 6 This score is derived from consideration of the patients clinical condition, lung function measurements, and x ray appearances. Scores for each of the elements are added together to give a total score with a maximum of 100 for a fit person.
Data were analysed using the Mann-Whitney U test.
Results
Altogether 197 questionnaires were sent out and 118 (60%) were returned; two did not have the patient's name and were excluded from the analysis. Eighty one (70%) respondents were currently receiving attendance allowance. Of these 35 (43%) had submitted an appeal before that allowance was granted and 12 (15%) had had their allowance stopped at some point. The mean delay between first applying for and receiving the allowance was 6-2 months (range 1-72).
Thirty five respondents were not receiving the allowance, 20 (57%) of these had applied unsuccessfully and 15 (43%) had never applied. Twelve (60%) of those applying unsuccessfully had appealed against the decision and four of these appeals were still outstanding. Six (30%) had had attendance allowance stopped and five of these had appealed unsuccessfully against this. Twenty (17%) of respondents were receiving mobility allowance and 18 of these were receiving attendance allowance.
The characteristics of the groups of patients receiving or not receiving attendance allowance are shown in the table.
The mean age of the group receiving attendance allowance was significantly less than that of the group refused the allowance (p<005) but did not differ from that of the group that had not applied. The modified Shwachman score was not significantly different for the three groups but did show a significant negative correlation with age for the group as a whole (r= -0-459, p<o05).
Discussion
The results of this study appear to confirm the belief held by patients with cystic fibrosis and their families that the granting of attendance allowance is often an arbitrary process. Cystic fibrosis is a progressive disease which worsens with age-as demonstrated in this study by the negative correlation of clinical score with increasing age. Despite this families with younger children are more likely to receive attendance allowance than those with older children. Additionally 15% of patients receiving the allowance had it stopped after review several years later.
There is no relationship between the clinical condition ofthe patient and receipt ofattendance allowance, indeed there were two patients affected to the degree that they received mobility allowance but did not receive attendance allowance.
In both of these conclusions this study confirmed those performed in Southampton7 and Cardiff. 8 The procedure for assessing claims is likely to be responsible for the inconsistencies revealed in these studies. Claimants fill in an application form with few clinical details and are then visited at home by a doctor employed by the Department of Social Security (DSS) who will not usually have specialist paediatric training. These doctors often appear not to understand cystic fibrosis (one parent reported being asked when her child had caught the condition) and may be deceived by the apparent well being of many older children on initial examination. Many applicants did not feel that the examining doctor understood the time implications of treatment for cystic fibrosis or the fact that the relative good health of some sufferers was a direct result of very hard work on the part of parents.
Altogether 81% of appeals against refusal of the allowance were successful; the majority of these were supported by a detailed report from the hospital team responsible for the applicant's care. Many parents felt that this report should have formed part of the initial application.
Some of those who had never applied for the allowance had not done so because they were unaware of its existence. This is obviously unacceptable and emphasises that clinicians need to inquire actively and to give advice about social as well as medical issues.
The disability living allowance
The disability living allowance, which has replaced the attendance and mobility allowances from April 1992 for those aged under 65 has two main components, one for care needs and one for mobility needs. It is possible to claim for and receive one component of the allowance independently of the other. The care component is paid at one of three rates with the higher and middle rates corresponding to the higher and lower rates of the attendance allowance. There is a new lower rate for persons needing some help during the day or needing help to prepare a meal if older than 16 years. The mobility component has two rates, the higher corresponding to the mobility allowance and the lower for persons able to walk but requiring supervision outdoors.
The application procedure for the disability living allowance is very different to that for the attendance allowance. Applicants must fill in two forms that together total 40 pages (some pages need not be completed if the mobility component is not being claimed).9 There is space on the form for two statements supporting the application, one from a person knowing the applicant and a second from a doctor or another professional; this space is limited to three column inches.
Once completed the claim form is assessed by a non-medical administrative officer using a DSS manual for guidance. This manual has been written with advice from the Disability Living Allowance Disability Allowance Board and contributions from many organisations representing people with disabilities. Further advice is available from medical staff from the Benefits Agency Medical Services based in the same building. Reports may be requested from professionals involved with the applicant or a medical examination may be requested-it is hoped that this will be needed in only a small proportion of cases (personal communication, Benefits Agency Medical Services).
Appeals against decisions are first dealt with by a different administrator based in the Benefits Agency office in North Fylde. If the applicant is still unhappy they may appeal to the Disability Appeal Tribunal, this is an independent board consisting of a legally qualified chairman, a doctor, and a third member experienced in the needs of disabled people.
A better allowance? The introduction of the disability living allowance appears to improve the likelihood of patients with cystic fibrosis receiving financial help. There has been a lot of publicity about the the new allowance which hopefully will increase awareness in both patients and professionals. The application forms give the claimant plenty of opportunity to state how their illness or disability affects them in their daily lives. It is particularly useful that disability and mobility components can be claimed using the same forms. The length and complexity of the forms, however, is likely to discourage many people from applying. It is likely to be important that professionals, particularly doctors, are prepared 
